miltefosine has been researched along with Hypopigmentation in 1 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
Hypopigmentation: A condition caused by a deficiency or a loss of melanin pigmentation in the epidermis, also known as hypomelanosis. Hypopigmentation can be localized or generalized, and may result from genetic defects, trauma, inflammation, or infections.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ansari, NA | 1 |
| Ramesh, V | 1 |
| Salotra, P | 1 |
1 other study available for miltefosine and Hypopigmentation
| Article | Year |
|---|---|
Immune response following miltefosine therapy in a patient with post-kala-azar dermal leishmaniasis.
Topics: Adolescent; Animals; Antiprotozoal Agents; Clofazimine; Diagnosis, Differential; Humans; Hypopigment | 2008 |